Publications by authors named "Hari Krishna Nallapaneni"

Article Synopsis
  • Tropomyosin receptor kinase A (TrkA) is a protein involved in neuron growth and survival, and its signaling can go haywire due to chromosomal rearrangements resulting in the TrkA fusion protein, often linked to certain cancers.
  • A study assessed the effectiveness of KRC-108, a benzoxazole compound, in inhibiting TrkA activity, showing it could block TrkA in lab tests and slow the growth of KM12C colon cancer cells with the fusion protein.
  • KRC-108 caused cancer cells to stop dividing, die off, and undergo autophagy, while also reducing the activity of key signaling proteins, suggesting it has potential as a treatment for cancers with TrkA fusion
View Article and Find Full Text PDF

Selective androgen receptor modulators (SARMs) are compounds with specific androgenic properties that have been investigated for the treatment of conditions such as muscle wasting disease. The reported androgenic properties have resulted in their use by athletes, and consequently they have been on the World Anti-Doping Agency prohibited list for more than a decade. To minimise the chance of an unattended positive doping test and to avoid potential serious health problems, adequate screening methods for the detection of a wide range of SARMs in these supplements is necessary.

View Article and Find Full Text PDF

The cross-metathesis (CM) of methallyl halides catalyzed using four different ruthenium-based complexes-Grubbs catalyst, Grubbs second-generation catalyst, Hoveyda-Grubbs second-generation catalyst, and Stewart-Grubbs catalyst-was investigated. When methallyl chloride or bromide was reacted with a model substrate containing a benzyl ether group, the Grubbs catalyst, and Grubbs second-generation catalyst did not promote the reaction well. However, the Hoveyda-Grubbs second-generation catalyst and Stewart-Grubbs catalyst afforded the corresponding products in moderate to good yield with moderate / selectivity.

View Article and Find Full Text PDF

A series of thieno[2,3-d]pyrimidine alkyne Mannich base derivatives (7a-e, 8a-e) and thieno[2,3-d]pyrimidine 1,3,4-oxadiazole derivatives (9a-e, 10a-e) have been synthesized and evaluated for their neuroprotective and neurotoxicity activities where 9a, 10d displayed good neuroprotection 10.6 and 11.88 µg/mL respectively against the HO induced cell death at the EC values and 9b, 9d showed respective toxic effects on PC12 cells at CC 86.

View Article and Find Full Text PDF